"Comparative Radiation Research"

Speaker: Charles A. Maitz, DVM, PhD, DACVR-RO, Associate Professor of Radiation Oncology, Department of Veterinary Medicine & Surgery, College of Veterinary Medicine, University of Missouri

Date: Feb. 20, 2025, 4:30-5:30 p.m.

Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room

*Zoom option available 

Register Here

Description

Dr. Maitz is an Associate Professor of Radiation Oncology in the Department of Veterinary Medicine and Surgery.  He also has an appointment as a MURR Research Scientist.  His research focuses on the improvement of treatment outcomes using radiation by maximizing the biologic dose to target tissues, while minimizing the dose to healthy, normal tissues.  His approach is comparative and translational at its core, leveraging the opportunity to provide treatment to veterinary patients to ultimately provide improved care to humans with cancer and select infectious diseases.  Through his appointments with MURR and MITC, he seeks to serve as a conduit of translation, helping design and carry out both preclinical and veterinary clinical studies of novel radiopharmaceuticals developed in the MU radiopharmaceutical pipeline.  Clinically, he is the Radiation Oncology Chief of Service in the Veterinary Health Center.  This service offers clinical investigations in veterinary radiotherapy through joint efforts with the Oncology Service and the VHC Clinical Research Office.  Through his research and clinical work, he is focused on the relationship between improving veterinary cancer care, uncovering the underpinnings of comparative radiation biology, and improving treatment outcomes by contributing to the translational development of highly targeted, highly potent forms of radiation.

About the Speaker

Dr. Maitz is a veterinary radiation oncologist with strong interests in clinical radiation therapy, comparative medicine, radiation biology and radiation dosimetry. He's had a research focus in translational models of high LET radiation including boron neutron capture therapy and targeted alpha therapy, as well as in neutron dosimetry and computational dose modeling. Much of this research uses Monte Carlo based computer modeling using Geant4 and Gate.

Research Interests: Traumatic spinal cord injury, regenerative medicine.

Clinical Interests: All aspects of neurology and neurosurgery.
 

About the Series

The goal of the NextGen Precision Health & Ellis Fischel Cancer Center Science Seminar is to highlight transdisciplinary precision research taking place in the cancer field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

For questions about this event, please reach out to Mackenzie Lynch.